Cao, L., Song, H., Wu, G., Gui, H. M., Xu, Q., Wang, C., Fan, D., Feng, Y., Zhou, C., Ming, J., Wang, X., Wang, J., Xu, H., Wu, Y., Jiang, B., Chu, H., Liu, G., Wu, Y., Zhu, X., Dai, Y., Ding, K. (2025). Data update of a single-arm, Phase II Study of orelabrutinib with/without Rituximab in patients with chronic lymphocytic leukemia/small Lymphocytic Lymphoma after BTK inhibitor therapy. Blood. https://doi.org/10.1182/blood-2025-7416